Department of Biophysics and Cell Biology

1.

Borrego, J., Naseem, M. U., Al Olaimi, A. S., Korpos, É., Szöőr, Á., Batta, G., Panyi, G.: A Fluorescent Protein-Tagged Scorpion Toxin with Picomolar Affinity for the Kv1.3 K+ Channel.
ACS Omega. 11 (9), 14681-14694, 2026.

doi DEA WoS Scopus

Journal metrics:

Q1 Chemical Engineering (miscellaneous) (2025)

Q2 Chemistry (miscellaneous) (2025)

2.

Fehér, Á., Domingos, G. J., Piga, M., Tomasic, T., Zidar, N., Varga, Z.: A kinetic trap mechanism underlies hHv1 inhibition by NZ-58.
J. Gen. Physiol. "Accepted by publisher", 2026.

DEA

Journal metrics:

Q2 Physiology (2025)

3.

Domingos, G. J., Fehér, Á., Teshome, R. T., Husain, S., Papp, F., Amna, A. O., Bangera, K. C., Vizi, Z., Elian, R., Kovács, Z. M., Szentandrássy, N., Piga, M., Tomasic, T., Zidar, N., Varga, Z.: A small molecule voltage-sensor modulator enhances the function of the cardiac NaV1.5 channel.
Biomed. Pharmacother. 200, 1-14, (article identifier: 119530), 2026.

doi DEA

Journal metrics:

D1 Medicine (miscellaneous) (2025)

D1 Pharmacology (2025)

4.

Serrano Cano, T. G., Yasari, A., Hartl, I., Tiemann-Boege, I., Nagy, P.: Biophysical characterization of recurrent ErbB2 missense mutations reveals alterations in receptor organization and membrane dynamics.
J. Mol. Biol. 438 (12), 1-18, (article identifier: 169770), 2026.

doi DEA Scopus

Journal metrics:

D1 Biophysics (2025)

Q1 Molecular Biology (2025)

D1 Structural Biology (2025)

5.

Wai, D. C. C., Koehn, L. M., Kreutzer, E., Runwal, P., Naseem, M. U., Panyi, G., Finkelstein, D. I., Nicolazzo, J. A., Norton, R. S.: Brain Delivery of a Kv1.3-Blocking Peptide is not Enhanced by Conjugation to Blood-Brain Barrier Shuttle Peptides.
Int J Pept Res Ther. 32 (2), 1-13, (article identifier: 30), 2026.

doi DEA WoS Scopus

6.

Gergely, B., Vereb, M. A., Rebenku, I., Szöőr, Á., Vereb, G.: Breaking the barrier: Synergistic 2B4.4-1BB signaling potentiates HER2-CAR NK cells to penetrate and destroy ADCC-resistant tumors.
Cancer Lett. 651, 1-9, (article identifier: 218534), 2026.

doi DEA

Journal metrics:

Q1 Cancer Research (2025)

D1 Oncology (2025)

7.

Ali, M. A., Papp, A. B., Garabuczi, É., Gere, Á., Dienes, B., Gönczi, M., Vámosi, G., Köröskényi, K., Csernoch, L., Szondy, Z., Sarang, Z.: CD47 Promotes, While Exposure to Apoptotic Cells Destroys the Fusion Program of Differentiating Myoblasts.
Faseb J. 40 (4), 1-17, (article identifier: 71578), 2026.

doi DEA WoS Scopus

Journal metrics:

Q1 Biochemistry (2025)

Q1 Biotechnology (2025)

Q1 Genetics (2025)

Q1 Medicine (miscellaneous) (2025)

Q2 Molecular Biology (2025)

8.

Gaál, S. M., Mészáros, B., Volkó, J., Bilakovics, N., Naseem, M. U., Pethő, Z., Sándorfi, G., Menkó, G., Vörös, O., Balogh, I., Panyi, G., Csanádi, Z., Szántó, G. T.: Characterization of the R893C NaV1.5 mutation in Brugada syndrome.
Front. Cardiovasc. Med. 13, 1-18, (article identifier: 1726536), 2026.

doi DEA

Journal metrics:

Q1 Cardiology and Cardiovascular Medicine (2025)

9.

Baddour, S., Szöllősi, J., Mátyus, L., Vámosi, G., Csomós, I., Dóczy-Bodnár, A.: Chelidonine Induces Concurrent Elevation of pSer-STAT3 and Bcl-2 Levels in a Mitotic Subpopulation of Human T-Leukemia/Lymphoma Cells.
Int. J. Mol. Sci. 27 (3), 1-21, (article identifier: 1200), 2026.

doi DEA WoS Scopus

Journal metrics:

Q1 Catalysis (2025)

Q1 Computer Science Applications (2025)

D1 Inorganic Chemistry (2025)

Q1 Medicine (miscellaneous) (2025)

Q2 Molecular Biology (2025)

D1 Organic Chemistry (2025)

Q1 Physical and Theoretical Chemistry (2025)

D1 Spectroscopy (2025)

10.

Kothalawala, R. C., Makay, C., Szente, L., Varga, Z., Panyi, G., Nagy, P., Zákány, F., Kovács, T.: Disorder in Order-Related Membrane Biophysical Parameters: an In-Depth Analysis of Di-4-ANEPPDHQ Generalized Polarization.
J. Phys. Chem. Lett. 17 (16), 4723-4731, 2026.

doi DEA WoS Scopus

Journal metrics:

Q1 Materials Science (miscellaneous) (2025)

Q1 Nanoscience and Nanotechnology (2025)

Q1 Physical and Theoretical Chemistry (2025)

11.

Kovács, P., Vágó, J., Mobasheri, A., Jenei-Lanzl, Z., Zaucke, F., Madry, H., Csernoch, L., Szekanecz, Z., Szondy, Z., Szöőr, Á., Szatmári, I., Oláh, T., Matta, C.: Emerging Concepts in Osteoarthritis and Musculoskeletal Diseases: insights from the University of Debrecen Musculoskeletal Symposium 2025.
Osteoarthr. Cartil. Open. 8 (1), 1-8, (article identifier: 100728), 2026.

doi DEA

Journal metrics:

Q2 Biomedical Engineering (2025)

Q1 Orthopedics and Sports Medicine (2025)

Q1 Rehabilitation (2025)

12.

Mianesaz, H., Göczi, L., Bojcsuk, D., Ghalamkari, S., Fadel, L., Póliska, S., Penyige, A., Nagy, L., Nagy, G., Vámosi, G., Széles, L.: Genome-wide chromatin profiling reveals a non-limiting role for RXR in macrophage-like cells stimulated with multiple nuclear receptor agonists.
J. Biol Chem. [Epub ahead of print], 2026.

DEA

Journal metrics:

Q1 Biochemistry (2025)

Q1 Cell Biology (2025)

Q1 Molecular Biology (2025)

13.

Huntošová, V., Baddour, S., Migasová, A., Bilakovics, N., Benziane, A., Salaková, M., Jurašeková, Z., Zelenka, T., Zelenková, G., Schubert, T., Zákány, F., Kovács, T., Chowdhury, A., Ambro, L., Dóczy-Bodnár, A., Szűcs, P., Váradi, J., Walter, A., Sedlák, E., Almáši, M., Vámosi, G.: Hierarchical Functionalisation of UiO-66(Zr)-NH2 with Cysteine, PEG, and SARS-CoV-2 Spike RBD to Facilitate ACE2 Receptor Targeting in Model Cells.
Nanomaterials. 16 (11), 1-27, (article identifier: 670), 2026.

doi DEA

Journal metrics:

Q1 Chemical Engineering (miscellaneous) (2025)

Q2 Materials Science (miscellaneous) (2025)

14.

Kovács, T., Kurtán, K., Pályi, B., Kis, Z., Mahdi, M., Borrego, J., Tőzsér, J., Varga, Z., Nagy, P., Panyi, G., Zákány, F.: The Selective DHCR24 Blocker SH42 Inhibits ACE2 Binding and Cellular Entry of SARS-CoV-2 Spike Proteins More Efficiently Than Atorvastatin.
Research. 9 (1280), 1-18, (article identifier: 1280), 2026.

doi DEA

Journal metrics:

D1 Multidisciplinary (2025)

15.

Obajed Al-Ali, N., Csige, D., Pinczés, L. I., Farkas, K., Rebenku, I., Domján, A., Panyi, G., Szekanecz, Z., Szűcs, G., Illés, Á., Váróczy, L.: Adipokines as Prognostic Biomarkers in Multiple Myeloma: a Case-Control Study.
Medicina (Kaunas). 61 (11), 1-13, (article identifier: 2065), 2025.

doi DEA

Journal metrics:

Q2 Medicine (miscellaneous)

16.

Gyöngyösi, A., Korpos, É., Kállai, J., Lányi, Á.: A mieloid eredetű szuppresszor sejtek szerepe a tumor mikrokörnyezetben, terápiás lehetőségek.
Immunol. Szle. 17 (1), 34-43, 2025.

DEA

17.

Takács, L., Bajdik, B., Nellamkuzhi, N. J., Kemenes, G., Lloyd, C. B., Vereb, M. A., Vereb, G.: Anterior segment optical coherence tomography of limbal palisade structure predicts corneal and limbal epithelial status in diabetic patients.
Invest. Ophthalmol. Vis. Sci. 66 (8), 4416, 2025.

DEA

18.

Shakeel, K., Olamendi-Portugal, T., Naseem, M. U., Becerril, B., Zamudio, F. Z., Delgado-Prudencio, G., Possani, L. D., Panyi, G.: Characterization of seven new K+ channel blocker peptides of Centruroides bonito revealed that α-KTx 2.24 has a picomolar affinity for Kv1.2.
Biophys. J. 124 (3), 602a, 2025.

doi DEA

19.

Nagy, L., Nagy, G., Juhász, T., Fillér, C., Szűcs, G., Szekanecz, Z., Vereb, G., Antal-Szalmás, P., Szöőr, Á.: Comparative Evaluation of Bleomycin- and Collagen-V-Induced Models of Systemic Sclerosis: insights into Fibrosis and Autoimmunity for Translational Research.
Int. J. Mol. Sci. 26 (6), 1-15, (article identifier: 2618), 2025.

doi DEA

Journal metrics:

Q1 Catalysis

Q1 Computer Science Applications

D1 Inorganic Chemistry

Q1 Medicine (miscellaneous)

Q2 Molecular Biology

D1 Organic Chemistry

Q1 Physical and Theoretical Chemistry

D1 Spectroscopy

20.

Pócsi, M., Fila, L., Péterfia, C., Halász, A., Szántó, G. T., Mészáros, B., Major, J., Laki, I., Szabó, H., Panyi, G., Balogh, I., Amaral, M. D., Macek, J. M., Nagy, B. J.: Comparison of the Effect of CFTR Modulators elexacaftor/tezacaftor/ivacaftor and lumacaftor/ivacaftor via Serum Human Epididymis Protein 4 Concentration in p.Phe508del-CFTR Homozygous Cystic Fibrosis Patients.
J Clin Med. 14 (17), 1-18, (article identifier: 6188), 2025.

doi DEA WoS Scopus

Journal metrics:

Q2 Medicine (miscellaneous)

21.

Kemenes, G., Rebenku, I., Bajdik, B., Vereb, G., Takács, L.: Correlation of Multimodal Clinical Imaging With the Whole-Slide- and Superresolution-Based Immunohistological Structure of the Corneal Limbal Stroma.
Invest. Ophthalmol. Vis. Sci. 66 (9), 1-13, (article identifier: 54), 2025.

doi DEA WoS Scopus

Journal metrics:

Q2 Cellular and Molecular Neuroscience

Q1 Ophthalmology

Q1 Sensory Systems

22.

Shakeel, K., Naseem, M. U., Olamendi-Portugal, T., Zamudio, F. Z., Possani, L. D., Panyi, G.: Cvill6 and Cvill7: Potent and Selective Peptide Blockers of Kv1.2 Ion Channel Isolated from Mexican Scorpion Centruroides villegasi.
Toxins. 17 (6), 1-19, (article identifier: 279), 2025.

doi DEA WoS Scopus

Journal metrics:

Q2 Health, Toxicology and Mutagenesis

Q2 Toxicology

23.

Óvári, J., Kovács, Z. M., Dienes, C., Magyar, J., Bányász, T., Nánási, P. P., Horváth, B., Domingos, G. J., Fehér, Á., Varga, Z., Szentandrássy, N.: Delavirdine modifies action potential configuration via inhibition of IKr and Ito in canine ventricular myocytes.
Biomed. Pharmacother. 186, 1-13, (article identifier: 117994), 2025.

doi DEA Scopus

Journal metrics:

D1 Medicine (miscellaneous)

D1 Pharmacology

24.

Kemenes, G., Rebenku, I., Vereb, G., Takács, L.: Developing an ex vivo human cornea model for discovering the cellular interactions in simple limbal epithelial transplantation.
Invest. Ophthalmol. Vis. Sci. 66 (8), 1042, 2025.

DEA

25.

Pourjamal, N., Le Joncour, V., Vereb, G., Honkamaki, C., Isola, J., Leyton, J. V., Laakkonen, P., Joensuu, H., Barok, M.: Disitamab vedotin in preclinical models of HER2-positive breast and gastric cancers resistant to trastuzumab emtansine and trastuzumab deruxtecan.
Translational Oncology. 53, 1-9, (article identifier: 102284), 2025.

doi DEA WoS Scopus

Journal metrics:

Q2 Cancer Research

Q1 Oncology

Department of Biophysics and Cell Biology

Publication list